Android app on Google Play

Dawson James Downgrades Cytokinetics (CYTK) to Market Outperform

November 27, 2012 9:16 AM EST Send to a Friend
Get Alerts CYTK Hot Sheet
Price: $3.61 -2.43%

Rating Summary:
    6 Buy, 2 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 19 | Down: 17 | New: 21
Trade CYTK Now!
Join SI Premium – FREE
Dawson James downgraded Cytokinetics (NASDAQ: CYTK) from to Market Outperform with a price target of $2.00.

For an analyst ratings summary and ratings history on Cytokinetics click here. For more ratings news on Cytokinetics click here.

Shares of Cytokinetics closed at $0.67 yesterday.




You May Also Be Interested In


Related Categories

Downgrades

Add Your Comment